AIDS-related primary central nervous system lymphoma

Yvette L. Kasamon, Richard F. Ambinder

Research output: Contribution to journalReview articlepeer-review

Abstract

Because survival of patients infected with HIV has improved with HAART, more patients diagnosed with PCNSL may become candidates for chemotherapy. The role of chemotherapy is far from established, however, and there are clear limitations to dose-intensive approaches in the setting of advanced HIV infection. Because of the rarity of this lymphoma, multicenter collaborations are needed to address these and other fundamental management questions. Further insights into the biology of AIDS PCNSL may translate into new and potentially less immunosuppressive treatments.

Original languageEnglish (US)
Pages (from-to)665-687
Number of pages23
JournalHematology/Oncology Clinics of North America
Volume19
Issue number4
DOIs
StatePublished - Aug 2005

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'AIDS-related primary central nervous system lymphoma'. Together they form a unique fingerprint.

Cite this